Sorina Suarasan

Learn More
In this work, we developed a new pH- and temperature-responsive nanochemotherapeutic system based on Doxorubicin (DOX) noncovalently bound to biosynthesized gelatin-coated gold nanoparticles (DOX-AuNPs@gelatin). The real-time release profile of DOX was evaluated at different pH values (7.4, 5.3, and 4.6) and temperatures (22-45 °C) in aqueous solutions, and(More)
It is well known that standard citrate-reduced gold nanoparticles (AuNPs) are unstable at high ionic strength solution, which limits their applications in the biomedical field. In this work we present an environmentally friendly approach for the stabilization of citrate-reduced AuNPs in aqueous solution. Specifically, the stability of the AuNPs against(More)
It is useful to find new methods to synthesize and, more importantly, to control the size and shape of gold nanoparticles (AuNPs) without using relatively toxic-reducing agents and surfactants. In this work, we present a one-pot, green synthesis of AuNPs taking the advantage of gelatin biopolymer to operate as unique reducing, growth controlling and(More)
BACKGROUND AND AIMS Every year, in Europe, acute myeloid leukemia (AML) is diagnosed in thousands of adults. For most subtypes of AML, the backbone of treatment was introduced nearly 40 years ago as a combination of cytosine arabinoside with an anthracycline. This therapy is still the worldwide standard of care. Two-thirds of patients achieve complete(More)
This study presents the design of a gold nanoparticle (AuNPs)-drug system with improved efficiency for the treatment of acute myeloid leukemia. The system is based on four different FLT3 inhibitors, namely midostaurin, sorafenib, lestaurtinib, and quizartinib, which were independently loaded onto gelatin-coated gold nanoparticles. Detailed investigation of(More)
Ovarian cancer is a common cause of cancer death in women and is associated with the highest mortality rates of all gynecological malignancies. Carboplatin (CBP) is the most used cytotoxic agent in the treatment of ovarian cancer. Herein, we design and assess a CBP nanotherapeutic delivery system which allows combinatorial functionalities of chemotherapy,(More)
  • 1